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Necrotizing enterocolitis (NEC) is a devastating morbidity usually seen in preterm infants, with extremely preterm neonates (EPT
≤28 weeks) considered at highest risk. Moderately preterm infants (MPT 28–34 weeks) constitute a large percentage of NICU
admissions. In our retrospective data analysis of NEC in a single regional perinatal center, NEC was observed in 10% of extremely
EPT and 7% of MPT, but only 0.7% of late-preterm/term admissions. There was an inverse relationship between postnatal age at
onset of NEC and gestational age at birth. Among MPT infants with NEC, maternal hypertensive disorders (29%) and small for
gestational age (SGA-15%) were more common than in EPT infants (11.6 and 4.6%, resp.). Congenital gastrointestinal anomalies
were common among late preterm/term infants with NEC. SGA MPT infants born to mothers with hypertensive disorders are
particularly at risk and should be closely monitored for signs of NEC. Identifying risk factors specific to each gestational age may
help clinicians to tailor interventions to prevent NEC.
1. Introduction
Necrotizing enterocolitis (NEC) is an acute inflammatory
necrosis of the bowel that primarily affects preterm infants
and remains a leading cause of mortality and morbidity
in neonatal intensive care units (NICU). Risk factors for
classic NEC include prematurity, a feeding insult, abnormal
bacterial flora, and intestinal ischemia/reperfusion injury
with activation of proinflammatory cytokines [1].While NEC
has been recognized as a morbidity in mostly extremely
preterm (EPT) neonates, a similar clinical condition occurs
in term infants as well. “Term NEC” (infants >37-week
gestational age) has also been studied in case series, with
unique risk factors identified such as congenital left sided
heart disease, hypoxic ischemic injury (perinatal asphyxia),
polycythemia, and maternal drug abuse (especially cocaine)
[2].
Most studies have focused on NEC in EPT infants <28-
week gestational age (GA), since this group is at highest risk.
Yet, it does occur in “older” preterm infants as well. NEC in
moderately preterm (MPT) infants is reported to occur at a
rate of∼1% [3, 4]-2.4%[5]. However, the total number ofMPT
births is much higher than EPT births: 9.5% vs 1.9% in the US
(March of Dimes Peristats, 2013). Thus, a significant number
of MPT infants are being diagnosed with NEC. It is plausible
that this subset of older gestation preterm infants has unique
risk factors and disease characteristics. Understanding these
factors may help us identify infants at risk and prevent this
devastating condition.
The purpose of our study was to describe NEC in MPT
infants (28–34-week GA at birth). We hypothesized that, in
comparison to the EPT group, MPT and late preterm/term
(LP/T) infants who develop NEC would have a higher
incidence of hemodynamic insults such as congenital heart
disease, small for gestational age (SGA), pregnancy-induced
hypertension (PIH)/preeclampsia, and perinatal asphyxia
evidenced by the need for advanced resuscitation at birth.
We also hypothesized that MPT infants who develop NEC
will have a lower incidence of surgical NEC compared to EPT
neonates.
2. Materials and Methods
This was a retrospective data analysis of all infants diagnosed
with NEC that were admitted to a single tertiary care NICU
over a period of 7 years from July 2009 to July 2016.The State
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Table 1: Baseline characteristics.
Characteristic EPT MPT LPT/T
Incidence of NEC as % of NICU admits at corresponding GA 10% (43/399) 7% (99/1359) 0.7% (30/4355)
GA at birth (weeks, mean ± SD) 25.5±1.4 30.5±1.7 36.1±1.8
Birth weight (kg) 0.77±0.18 1.41±0.37 2.54±0.6
Postnatal day at onset of NEC (d) 25.9±18 18±15 12.7±16.2
Postmenstrual age at diagnosis (weeks) 29.2±2.4 33.1±2.2 37.9±2.9
Table 2: Ante and Perinatal risk factors for NEC.
Characteristic EPT (n=43) MPT (n=99) LPT/T (n=30) P value
Chorioamnionitis 5 (11.6%) 7 (7) 1 (3.3%) 0.4
Maternal hypertensive disorders 5 (11.6%) 29(29%) 5 (16%) 0.04∗
5 min APGAR score ≤ 5 3 (6.9%) 2 (2%) 1 (3.3%) NS
Small for gestational age 2 (4.6%) 15 (15%) 8 (27%) 0.02∗
University of New York at Buffalo Institutional Review Board
(IRB) approval was obtained prior to data collection, and an
exemption to individual parental consent was granted.
Infants were included with a diagnosis of NEC stage 2 or
higher byModified Bell’s staging [6]. All the following criteria
had to bemet to confirm the diagnosis ofNEC: (1) At least one
abdominal radiograph with evidence of pneumatosis intesti-
nalis reported by a pediatric radiologist; (2) clinical decision
to treat with ≥ 7 days of antibiotics; and (3) withholding feeds
for ≥ 7 days. Infants with incomplete maternal and birth data,
especially those that were transferred in from other facilities
with a diagnosis of NEC, were excluded. Other exclusions
were infants with a diagnosis of NEC that was later ruled
out in documentation by the attending physician and those
without evidence of pneumatosis on imaging studies.
Subjects were divided into three groups based uponGA at
birth: extremely preterm (EPT< 28weeks),moderate preterm
(MPT-28 to 33 6/7 weeks), and late preterm/term (LPT/T>
34 weeks). Differences between the groups were tested using
Chi-squared test for categorical variables and ANOVA for
continuous normally distributed variables. Results were con-
sidered significant when p < 0.05.
3. Results
3.1. Baseline Data. Out of 6113 admissions to the NICU, 172
patients (2.8%) developed NEC (Table 1). Incidence of NEC
decreased with increasing GA. The incidence of NEC in
infants between 28 and 336/7 weeks was 7%.There were more
MPT infants with NEC (n=99) compared to the other two
GA groups (n=73). There was an inverse relationship noted
with postnatal age at presentation of NEC in relation to GA
at birth (Figure 1), and most of the infants in our study group
presented at an averageGAof 29-33weeks. A large percentage
of infants over 35weeks are not admitted to our NICU; hence,
as a percentage of total hospital births >34 weeks, incidence
of NEC in near term infants was 0.4% (30 infants withNEC in
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Figure 1: Inverse relationship between gestational age at birth and
postnatal day at diagnosis of NEC. Each infant represented by a
circle. Black circles represent the infants with congenital gastroin-
testinal anomalies (gastroschisis and Hirschsprung’s disease).
3.2. Risk Factors. The MPT and LPT/T cohorts with NEC
had a significantly larger percentage of infants who were
SGA (15% and 27% vs 4.6% in EPT) (Table 2). Additionally, a
significantly higher number of infants born MPT were noted
to be exposed to maternal hypertensive disorders than the
EPT group and LPT/T group (24.4% vs 14% and 16%, resp.).
There was no difference in the incidence of low APGAR
scores at 5 min in the 3 groups, which was taken as in
indicator of need for prolonged resuscitation.
3.3. Clinical Factors Prior to NEC. Presence of clinical factors
that could have contributed to NEC was assessed among the
three groups (Table 3). EPT infants with NEC had a higher
incidence of hypotension soon after birth. Increased use of
formula feeds as reflected by a mixed diet was noted in
EPT and MPT compared to LPT/T. A significantly higher
number of antibiotic days were noted in EPT infants prior
to a diagnosis of NEC. The preterm cohorts also had a lower
haematocrit, with more infants receiving a packed red cell
(PRBC) transfusion prior to the diagnosis of NEC. Most
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Table 3: Clinical factors prior to diagnosis of NEC.
Characteristic EPT (n=43) MPT (n=99) LPT/T (n=30) P value
Hypotension in first 24 hrs after birth 9 (20.9%) 4 (4%) 0 0.0005∗
Exclusive breast milk 2 (4.6%) 1(1%) 2 (6.6%) NS
Mixed Diet (formula and breast milk) 32 (74.4%) 76 (76.8%) 16 (53.4%) 0.04∗
Exclusive formula diet 9 (21%) 23 (23%) 12 (40%) NS
Antibiotic days prior to NEC 7.7±4.5 4.9±3.5 5.8±3.5 0.002∗
Hematocrit at diagnosis (%) 33.5±5.6 34.5±6.3 41.8±10.4 0.005∗
Transfusion in the 48hrs prior to diagnosis 11 (25.6%) 12 (12.1%) 0% 0.02∗
Congenital Gastrointestinal abnormalities† 0 7 (7%) 6 (20%) 0.006∗
Genetic/congenital non GI abnormalities‡ 0 5 (5%) 3 (10%) 0.13
† Congenital GI anomalies included gastroschisis (4), Hirschsprung’s disease, imperforate anus, jejunal atresia and Meckels diverticulum. ‡ Genetic/non GI
abnormalities included Trisomy 13, Trisomy 21, congenital myopathy, meningomyelocele and 17q21 deletion.
Table 4: Outcome characteristics.
Characteristic EPT (n=43) MPT (n=99) LPT/T (n=30) P value
Colonic NEC 0 19 (19.19%) 10 (30.03%) 0.0006∗
Surgical NEC 22 (53%) 20 (21%) 1 (3.3%) 0.0031∗
Death before discharge 8 (18.6%) 9 (9%) 1 (3.3%) 0.08
congenital anomalies, gastrointestinal (GI) as well as genetic,
were noted in MPT and LPT/T groups.
3.4. Outcome Characteristics. Exclusive involvement of the
colon was more common, and need for surgery was less
common with increasing gestation (Table 4). While not
statistically significant, EPT infants showed a trend towards
higher mortality from NEC.
4. Discussion
Necrotizing enterocolitis is the most common abdominal
emergency of the preterm infant. We present this retrospec-
tive review to highlight the large number of MPT infants
presenting with NEC and outline the morbidities associated
with NEC.
Though GA is a continuum, different GA categories may
have characteristic risk factors and clinical signs of disease.
Over the last decade, mortality and morbidity among the
MPT and LPT infants has received significant attention [7].
In currently available literature, there is little consensus on
the definition of a MPT infant. Infants born between 28
and 34 weeks have been included in some studies, while
others have focused on 32–34-week GA. Due to the high
number of infants being delivered at this GA range, they
constitute a significant healthcare burden. In a single center
study, infants born at 28–34-week GA constitute ∼37% of all
NICU admissions and ∼45% of NICU costs [8].
In our single center retrospective study of all inborn
infants with stage 2 or greater NEC, we have noted an inverse
relation between GA at birth and postnatal age at onset of
disease (Figure 1). The EPT cohort (mean GA 25.5 weeks)
developed NEC at ∼25d, and the LPT/T cohort showed onset
of disease much earlier (∼13 d). This has been previously
described in multiple epidemiological studies [9, 10], though
the exact reason is not well understood. Possible reasons
include inherent ontogeny of the vasculature development
[11], change in microbiome [12], and age and gestation
related changes in the inflammatory pathway such as toll-like
receptor 4 (TLR-4) [13].
We noted a significantly higher percentage of MPT
infants withNEC exposed tomaternal hypertensive disorders
compared to the other GA groups. Maternal hypertensive
disorders, especially preeclampsia and eclampsia, are thought
to predispose preterm infants to NEC. In a single center
observational study, infants born to preeclamptic mothers
had a higher incidence ofNEC (22.9% vs 14.6%), earlier onset,
more advanced stages of disease, and longer duration of
illness as compared to infants born to normotensive mothers
[14]. Contradictory findings have been demonstrated in sev-
eral studies [15] including a large Swedish national health care
analysis failing to show any significant correlation between
preeclampsia and NEC [16]. A direct association cannot be
determined from our findings as the majority of hypertensive
disorders of pregnancy present only at term or late preterm,
with just 10%–13% being diagnosed before 32 weeks [17].
In our study, MPT and LPT/T infants with NEC were
more likely to be SGA. A retrospective study on infants with
surgical NEC in Stockholm county also noted similar results
with a higher incidence of intrauterine growth restriction
(IUGR) in more mature infants (>28 weeks) [18]. IUGR is
postulated to cause persistent hypoxia and ischemia by alter-
ing blood flow to the intestines [19]. Another retrospective
study also found a higher risk of NEC in SGA neonates
compared to appropriate for gestational age (AGA) neonates
[20].
Another potential risk factor for NECwith similar patho-
physiology is a hypoxic ischemic insult [21]. Coagulation
necrosis and features specific to ischemic injury noted in
intestinal samples of infants with NEC suggested ischemic
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Figure 2: Salient risk factors for NEC noted in term and EPT infants are shown here.MPT infants share some characteristics of both groups,
mostly related to a vascular etiology such as anaemia/transfusion and SGA status.
injury as a major mechanism [22]. Rodent models of NEC
were developed by an asphyxial insult in combination with
enteral feeding [23]. In this study, we used APGAR scores
to reflect the need for advanced resuscitation, in the absence
of precise data on frequency of chest compressions and
epinephrine use at delivery. Contrary to our hypothesis, MPT
infants with NEC did not have an increased incidence of low
APGAR scores compared to other age groups. As we did
not analyse non-NEC infants, we cannot accurately assess
if advanced resuscitation is in fact related to NEC or just
a feature of immaturity. In a secondary analysis of MPT
infants 290/7 to 33
6/7 weeks’ GA enrolled in the Neonatal
Research Network Moderate Preterm Registry, the rate of
NEC progressively increased with the level of resuscitation;
however, on logistic regression analysis after adjusting for
covariates, the level of resuscitation did not statistically affect
the incidence of NEC [24]. In a similar analysis of EPT
infants, DeMauro et al. also showed a statistically insignifi-
cant relationship between observed rates of NEC and levels
of resuscitation [25].
Chorioamnionitis and resulting inflammation of the feto-
placental unit are thought to contribute to neonatal morbid-
ity. Recent studies have, however, failed to demonstrate an
association of clinical or histological chorioamnionitis with
NEC [26]. We did not find any difference in the incidence
of reported chorioamnionitis in our study infants. In spite of
this, EPT infants were noted to have a significantly higher
number of antibiotic days prior to NEC. The frequent use
of antibiotics postnatally in EPT infants is well described
in the literature, with one study noting that 96% received
early empirical antibiotics and 53% received more than 4
days of therapy [27]. High rate of initial antibiotic use is
also related to the development of NEC, though attempting
to establish this correlation was out of the scope of our
study.
Discrete clinical characteristics of NEC in the MPT
infants seemed to overlapwith EPTgroups.MPT infantswere
similar to EPT in receiving a mixed diet, being anaemic at
onset of disease and having a history of PRBC transfusions
just prior to diagnosis (Figure 2). Transfusion associatedNEC
or gut injury [28] has been described in anaemic preterm
infants that are on a significant amount of enteral feeds [29].
A vascular etiology [30] has beenpostulatedwith alteration of
the nitric oxide (NO) pathway; however, this entity remains
controversial. The surprisingly high incidence of associated
PRBC transfusions that we noted in the MPT group warrants
BioMed Research International 5
further evaluation and monitoring of anaemia in this poten-
tially lower risk population.
Infants with NEC in the MPT group also share some
characteristics similar to LPT/T infants (presence of congen-
ital anomalies, colonic NEC, and decreased need for surgical
intervention). Exclusive involvement of the colon was not
observed in EPT infants. Colonic involvement is more likely
to present with bloody stools, and this finding has been
described more commonly in > 28-week gestation infants
with NEC than in extremely preterm infants [18]. Similar
results were demonstrated in the moderate preterm NRN
registry, with MPT more likely to be treated with medical
treatment only vs EPT (1.7% vs 4% of all MPT and EPT
infants) [5]. Mortality rates in this disease for term infants
(4.7%) have also been reported to be less than premature
infants (11.9%) [31].
5. Limitations
This is a retrospective data analysis of infants born at a single
regional perinatal center. Only data recorded in the EMR
could be collected. We do not have data on control infants
at the same GA that did not develop this condition.
The incidence of NEC among MPT infants in our study
is considerably higher than the previously reported data. Our
institution is a Women and Children’s Hospital with a large
maternal transport service leading to a higher number of
high-risk obstetric population including hypertensive dis-
orders of pregnancy. However, we feel that the antecedent
factors and clinical characteristics observed in our cohort are
applicable to general population.
6. Conclusions
MPT infants who develop NEC may have risk and disease
characteristics that overlap with both LPT/T and EPT groups.
While reduced intestinal oxygen delivery (from hemody-
namic factors such as hypotension or anaemia/transfusion)
continues to be associated with NEC in MPT infants, they
also tend to have associated congenital anomalies. Prenatal
vascular factors (maternal hypertensive disorder and growth
restriction) appear to play a major role in NEC in MPT
infants. Recognition of these risk factors in this cohort may
help in screening for NEC as well as in developing care
practices for at risk infants.
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